Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (90.91 KB, 1 trang )
circulatory or vascular conditions and, 142
differential diagnosis, 141 –143
evaluation and decision, 143 –145 , 144 f
history, 143
laboratory evaluation, 144 –145
level of deoxygenated Hb and, 141
lung dysfunction and, 142
pathophysiology, 141
peripheral, 144
physical examination, 143 –144
pulmonary vascular abnormalities and, 143
ventilation/perfusion (V/Q) mismatch and, 141
Cyclic adenosine monophosphate (cAMP), 1044
Cyclic vomiting syndrome (CVS), 554 , 886
Cycloplegic eye drops, 1271
Cystic fibrosis (CF), 130 , 132 , 142 , 502 , 574 , 946 –949 , 948 t
Cystic hygromas (lymphangiomas), 317 , 320 , 1350
Cystic lung disorders, 1415 –1416
Cystic mediastinal lesions, 1419 –1420
Cystinuria, 337
Cystitis, 384 t
Cystosarcoma phyllodes, 113
Cytomegalovirus (CMV), 223 , 308 , 315 , 426 , 475
Cytopathic hypoxia, 74
Cytopenias, 905
D
Dacryocystitis, 1395 , 1402 , 1402 f
Dactylitis, 164
Dandy-Walker malformation, 1385
Danger-associated molecular patterns (DAMPs), 74